Search Results - "Jost, W H"

An updated calculator for determining levodopa-equivalent dose by Nyholm, D., Jost, W. H.

“…Abstract Calculation of levodopa-equivalent dose in Parkinson’s disease has become common in research, but is also a useful tool in clinical practice,…”
Get full text

Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management by Warnecke, T., Schäfer, K-H., Claus, I., Del Tredici, K., Jost, W. H.

“…Growing evidence suggests an increasing significance for the extent of gastrointestinal tract (GIT) dysfunction in Parkinson’s disease (PD). Most patients…”
Get full text

A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia by BENECKE, R, JOST, W. H, KANOVSKY, P, RUZICKA, E, COMES, G, GRAFE, S

“…A new botulinum toxin type A free of complexing proteins (NT 201) was compared with BOTOX in patients with cervical dystonia by means of a double-blind…”
Get full text

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm by Roggenkämper, P, Jost, W H, Bihari, K, Comes, G, Grafe, S

“…NT 201 is a new development of Botulinum Toxin Type A free of complexing proteins. In this double-blind Phase III trial, we compared the efficacy and safety of…”
Get full text

One hundred cases of anal fissure treated with botulin toxin: early and long-term results by Jost, W H

“…Sphincterotomy still is considered the therapy of choice to eliminate sphincter spasm in the treatment of uncomplicated chronic anal fissure. The surgery is…”
Get more information

Effectiveness of botulinum neurotoxin type A injections in naïve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance study by Jost, W.H., Schramm, A., Müngersdorf, M., Stenner, A., Schwingenschuh, P., Maisonobe, P., Koch, M., Haslinger, B.

“…AbobotulinumtoxinA (aboBoNT-A; Dysport®) is an effective treatment for cervical dystonia (CD) with a well-established safety profile. In this prospective,…”
Get full text

Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review by Oikonomou, P., Jost, W. H.

“…Anecdotal references, preclinical, and non-randomized studies support the therapeutic potential of cannabinoids for movement disorders (MD). To create an…”
Get full text

Anatomy and cervical dystonia: Dysfunction follows form by Tatu, L., Jost, W. H.

“…At first glance, cervical dystonia might be an illustration of the well-known proposition “function follows form”. Nevertheless, cervical dystonia is a highly…”
Get full text

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study by Graf, M, Ecker, D, Horowski, R, Kramer, B, Riederer, P, Gerlach, M, Hager, C, Ludolph, A C, Becker, G, Osterhage, J, Jost, W H, Schrank, B, Stein, C, Kostopulos, P, Lubik, S, Wekwerth, K, Dengler, R, Troeger, M, Wuerz, A, Hoge, A, Schrader, C, Schimke, N, Krampfl, K, Petri, S, Zierz, S, Eger, K, Neudecker, S, Traufeller, K, Sievert, M, Neundörfer, B, Hecht, M

“…Increasing evidence has suggested that oxidative stress may be involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). The antioxidant vitamin E…”
Get full text

Autonomic Disorders in Multiple Sclerosis by Lensch, E., Jost, Wolfgang H.

“…Multiple sclerosis is an inflammatory disease leading to disseminated lesions of the central nervous system resulting in both somatomotor and autonomic…”
Get full text

Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome by Grund, K. E., Zipfel, A., Duckworth-Mothes, B., Jost, W. H.

“…Pump-guided intrajejunal levodopa administration is one of the indispensable forms of therapy in advanced Parkinson's syndrome, along with deep brain…”
Get full text

Other indications of botulinum toxin therapy by Jost, W. H.

“…The therapeutic possibilities of botulinum toxin are manifold and certainly not yet fully exhausted. Apart from the classical indications – focal dystonia and…”
Get full text

Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers by Jost, W H, Kohl, A, Brinkmann, S, Comes, G

“…This randomized controlled trial was performed to compare the novel botulinum toxin type A free of complexing proteins (NT 201) with the marketed preparation…”
Get full text

Implications of dopaminergic medication withdrawal in Parkinson’s disease by Koschel, J., Ray Chaudhuri, K., Tönges, L., Thiel, M., Raeder, V., Jost, W. H.

“…The trajectory of the use of dopamine replacement therapy (DRT) in Parkinson’s disease (PD) is variable and doses may need to be increased, but also tapered…”
Get full text

Nonmotor symptoms in Parkinson's disease by Jost, W H

“…Parkinson's disease is a neurodegenerative disease that affects the peripheral and central nervous system. In addition to the motor symptoms, a large number of…”
Get full text

Constipation in Idiopathic Parkinson's Disease by JOST, W. H, ECKARDT, V. F

Get full text

Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies by Moes, H. R., Dafsari, H. S., Jost, W. H., Kovacs, N., Pirtošek, Z., Henriksen, T., Falup-Pecurariu, C., Minár, M., Buskens, E., van Laar, T.

“…Several screening tools are available to assist general neurologists in the timely identification of patients with advanced Parkinson’s disease (PD) who may be…”
Get full text

Treatment of drooling in Parkinson's disease with botulinum toxin by Jost, Wolfgang H.

Get full text

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease by Jenner, P., Falup-Pecurariu, C., Leta, V., Verin, M., Auffret, M., Bhidayasiri, Roongroj, Weiss, D., Borovečki, F., Jost, W. H.

“…Dopaminergic therapies dominate the treatment of the motor and non-motor symptoms of Parkinson’s disease (PD) but there have been no major advances in therapy…”
Get full text

Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation by Lubik, S, Fogel, W, Tronnier, V, Krause, M, König, J, Jost, W H

“…The aim of our study was to observe the effects on gait parameters induced by STN stimulation and levodopa medication in patients with advanced Parkinson's…”
Get full text